Microbix Biosystems (TSX:MBX) Total Liabilities : C$10.40 Mil (As of Dec. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Total Liabilities?

Microbix Biosystems's Total Liabilities for the quarter that ended in Dec. 2024 was C$10.40 Mil.

Microbix Biosystems's quarterly Total Liabilities increased from Jun. 2024 (C$9.71 Mil) to Sep. 2024 (C$9.80 Mil) and increased from Sep. 2024 (C$9.80 Mil) to Dec. 2024 (C$10.40 Mil).

Microbix Biosystems's annual Total Liabilities increased from Sep. 2022 (C$8.21 Mil) to Sep. 2023 (C$11.03 Mil) but then declined from Sep. 2023 (C$11.03 Mil) to Sep. 2024 (C$9.80 Mil).

Microbix Biosystems Total Liabilities Historical Data

The historical data trend for Microbix Biosystems's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Total Liabilities Chart

Microbix Biosystems Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Total Liabilities

Get a 7-Day Free Trial

8.98

10.27

8.21

11.03

9.80

Microbix Biosystems Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															9.48	10.17	9.71	9.80	10.40

Microbix Biosystems Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Microbix Biosystems's Total Liabilities for the fiscal year that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.395	+	(6.155	+	0.249
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	9.80

Total Liabilities	=	Total Assets (A: Sep. 2024 )	-	Total Equity (A: Sep. 2024 )
	=	38.097	-	28.297
	=	9.80

Microbix Biosystems's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.879	+	(6.22	+	0.3
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	10.40

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	39.299	-	28.9
	=	10.40

Microbix Biosystems Total Liabilities Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MBXBF:USA

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.

Executives

James Stuart Currie	Senior Officer
Mark Adrian Luscher	Senior Officer
Bo Hollas	Director
Jennifer Anne Stewart	Director
Cameron Lionel Groome	Director, Senior Officer
Kenneth Hughes	Senior Officer
Martin Marino	Director
Peter Martin Blecher	Director
Philip Jonathan Casselli	Senior Officer
Steven Trevor Hagerman	Senior Officer
Damian Klimaszewski	Senior Officer
Anthony J. Giovinazzo	Director